Quick Answer
GoodRx Holdings, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $796.85 million for the year ending 2025.
- GoodRx Holdings, Inc. showed an increase of +0.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from GoodRx Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), GoodRx Holdings, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 219.4%.
- Historical annual values: Fiscal year 2025: $796.85 million | Fiscal year 2024: $792.32 million | Fiscal year 2023: $750.27 million | Fiscal year 2022: $766.55 million | Fiscal year 2021: $745.42 million | Fiscal year 2020: $550.70 million | Fiscal year 2019: $388.22 million | Fiscal year 2018: $249.52 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: